Benign tumors may be a stage of development of malignant tumors.
Benign tumors consist primarily of homotypic cells with morphology being not significantly different from that of normal ones. These cells have a slight growth potential without invasive and metastatic abilities. Many benign cells keep these characteristics throughout life of a person and are regenerated as malignant ones rarely.
Benign tumors must be treated by specialists.
EnergoIod preparation is effective in prevention and combination therapy of benign tumors. Oncopreventive and antitumoral effects are connected with the following effects of the preparation:
- antimutagenic effect I prevention of changes in genetic apparatus of cells leading to risk of cancerous degeneration;
- adaptogenic effect - ability to bind carcinogenic agents and eliminate them from organism;
- antiestrogenic effect - prevention of development of hormone-dependent tumors in female genital system;
- normalization of thyroid functions;
- normalization of functions of reproductive hormones;
- normalization of immunity - normalization of hyperactivity or hypoactivity of immune system;
- anti-inflammatory effect entails indirect antitumoral effect;
- antiviral effect of the preparation (viral theory of origination of tumors is justifiable);
- antibacterial effect of the preparation allows to prevent infectious complications.
We hope that EnergoIod will help you to treat and prevent benign tumors successfully!
Use of EnergoIod in this disease
Use of EnergoIod in this disease
Weight, kg
For disease
Lung disease
Average disease
Severe disease
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
Single dose, ml
Daily dose, ml
40
2
4
4
8
6
12
50-60
3
6
6
12
9
18
70-80
4
8
8
16
12
24
90-100
5
10
10
20
15
30
110-120
6
12
12
24
17
34
Use of a concentrate
Shake before use. It requires dilution with cold or cool drinking water (in an amount of 100-200 ml).
The daily dose calculated for 1 kg body weight, depending on the severity and course of the disease is 0.1-0.3 ml / kg body weight / day, divided into 2 doses.
The drug is taken on an empty stomach in the morning and in the evening before going to bed for 30 days.
If necessary, a second course in 15 days.
The number of courses per year depending on the severity of the pathological process.
Carrying out an accelerated rate with the maximum dose for 15 days.